ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Yi Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-5114-0183; OpenAlex author ID A5055316584. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. Last author DOI 10.3390/biomedicines13071733 ↗
The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analy… Co-author DOI 10.3390/cancers16050971 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Gong · 2 shared papers, 2024–2025 · strength 0.44
- Paper Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. DOI 10.3390/biomedicines13071733 ↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Stephen Jacob Pandol · 2 shared papers, 2024–2025 · strength 0.44
- Paper Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. DOI 10.3390/biomedicines13071733 ↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Debiao Li · 2 shared papers, 2024–2025 · strength 0.44
- Paper Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. DOI 10.3390/biomedicines13071733 ↗
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Zijin Lin · 1 shared paper, 2025 · strength 0.26
- Paper Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. DOI 10.3390/biomedicines13071733 ↗
Touseef Ahmad Qureshi · 1 shared paper, 2025 · strength 0.26
- Paper Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities. DOI 10.3390/biomedicines13071733 ↗
Simon K. Lo · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Brent K. Larson · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Yazan Abboud · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Nicholas N. Nissen · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Srinivas Gaddam · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗
Arsen Osipov · 1 shared paper, 2024 · strength 0.18
- Paper The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocri… DOI 10.3390/cancers16050971 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.